menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Relapsed/Refractory CLL Care: Tailoring Treatment and Addressing Adverse Events

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Related
Comments
  • Sponsored by

  • Overview

    To ensure that patients with relapsed/refractory chronic lymphocytic leukemia (CLL) have the best opportunity for treatment success, it’s important to craft a personalized plan that prioritizes both treatment efficacy and a patient’s goals and quality of life. Joining Dr. Charles Turck to share best practices for creating individualized treatment plans for relapsed/refractory CLL that incorporate patient preferences and proactive symptom management is Dr. Adam Kittai, Assistant Professor in the Division of Hematology at the Ohio State University Comprehensive Cancer Center.

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • Sponsored by

  • Overview

    To ensure that patients with relapsed/refractory chronic lymphocytic leukemia (CLL) have the best opportunity for treatment success, it’s important to craft a personalized plan that prioritizes both treatment efficacy and a patient’s goals and quality of life. Joining Dr. Charles Turck to share best practices for creating individualized treatment plans for relapsed/refractory CLL that incorporate patient preferences and proactive symptom management is Dr. Adam Kittai, Assistant Professor in the Division of Hematology at the Ohio State University Comprehensive Cancer Center.

Facebook Comments

Schedule29 May 2024